Medpace Holdings is trading at $619.60, up +4.06% as defensive healthcare-sector strength supports the move.

  • No major company-specific announcement or earnings release was identified for September 15, 2026.
  • Healthcare is outperforming as investors favor defensive sectors while major indexes decline amid elevated yields, oil prices, and Federal Reserve uncertainty.
  • Jefferies reiterated a Hold rating with a $560 target, which does not clearly explain the rally; the move is best attributed to sector strength and defensive positioning.